Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4928 results

Sort By:

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Hospitalizations

Study ID: NCT06846879
Start Date: 2025-09
End Date: 2027-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

240000

Intervention / Treatment
Sponsor

Mario Negri Institute for Pharmacological Research

Source: clinicaltrials.gov

Share:
Add to list

Phenotypes Associated With Constitutional EGFR Pathogenic Variants

Study ID: NCT06562491
Start Date: 2025-09
End Date: 2025-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment
Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

Study ID: NCT06921317
Start Date: 2025-10
End Date: 2027-02-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

GVB-2001-high dose

GVB-2001-low dose

Sponsor

IVIEW Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF

Study ID: NCT06666335
Start Date: 2025-09-01
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

3

Intervention / Treatment

Anekinra

Sponsor

Swedish Orphan Biovitrum

Source: clinicaltrials.gov

Share:
Add to list

Acceptance and Commitment Therapy for Chemsex

Study ID: NCT06980974
Start Date: 2025-12-01
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

ACT-for-chemsex

Treatment as Usual (TAU)

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling

Study ID: NCT06813274
Start Date: 2025-10-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

160

Intervention / Treatment

hypoglycemic treatment

Tangshen'an Granules

Ginkgo Leaf Tablets

Mecobalamin tablets

placebo

Sponsor

He will be dissatisfied

Source: clinicaltrials.gov

Share:
Add to list

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Study ID: NCT06176690
Start Date: 2025-10-01
End Date: 2043-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

90

Intervention / Treatment

C7R.CD30.CAR-EBVST cells

Sponsor

Baylor College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Sexual and Urinary Function Improvement for Cancer Survivors

Study ID: NCT06637852
Start Date: 2026-10-01
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

SUFICS-PACT

Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

Infrared Photobiomodulation in Humans With Epilepsy

Study ID: NCT07145489
Start Date: 2025-09-25
End Date: 2027-09-25
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

13

Intervention / Treatment

photobiomodulation

Sponsor

Beth Israel Deaconess Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers

Study ID: NCT07061613
Start Date: 2025-09-01
End Date: 2026-03-29
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

NeoThelium FT (HCT/P 361)

Sponsor

NuScience Medical Biologics, LLC

Source: clinicaltrials.gov

Share:
Add to list